The High Authority for Health (HAS) recommended on Monday to reserve vaccination with the Janssen vaccine for certain cases at risk of severe forms of Covid pending the conclusions of the European Medicines Agency (EMA).
According to the HAS, the preliminary results of a study suggest a slight increase in the risk of myocardial infarction within two weeks of the injection of the Janssen vaccine at the adults of under 75.
The However, the High Health Authority reminds that this is preliminary data and that these need to be confirmed by further studies at the international level, including an EMA review.
Pending the conclusions of the EMA, the HAS recommends postponing injections with the Janssen vaccineexcept in people at risk of severe disease who have a contraindication for messenger RNA vaccines
–
